English (United States)
 

DxSeq-HIV

Pathology : Infectious Diseases
reduce font Size enlarge font Size print content

Study Title

Sample Collection for Validation and Evaluation of DxSeq_HIV

Study Detail

Study Objective


The objective is to evaluate the diagnostic tests. The results obtained from this study will help to develop new diagnostic blood tests so that targeted treatment options could be offered to patients in the future.

Participation conditions

Inclusion criteria


Group HIV-1 :
• Patient inform consent signed
• Patient age ≥ 18 years old (or legal age if greater than 18)
• HIV-1 positive patients at drug therapy failure with viral load ≥ 1000 cp/mL before therapy switch
• HIV-1 infected patients at initial presentation before initial drug therapy with viral load ≥ 1000 cp/ml

Group Control:
• Patient inform consent signed
• Patient age ≥ 18 years old (or legal age if greater than 18)
• Patient has one of these infections : HIV-2, HBV, HCV, CMV, EBV, with high viral load

Exclusion criteria


None
 

Centers

Centre Hospitalier de Luxembourg

Contact person

Charlotte Lieunard
charlotte.lieunard@crp-sante.lu
+352 26 970 847

Tags: HIV, DxSeq-HIV, validation

Studies overview

This page provides the list of clinical studies currently registered in the LuxCLIN platform in the different therapeutic areas. By clicking on each study title, more information is displayed concerning the study objective and the participation conditions.